Provided by Tiger Trade Technology Pte. Ltd.

ATIF Holdings Limited

6.80
+0.43996.92%
Post-market: 6.800.00000.00%16:10 EDT
Volume:469
Turnover:3K
Market Cap:70.13M
PE:-3.02
High:6.80
Open:6.80
Low:6.80
Close:6.36
52wk High:11.94
52wk Low:4.14
Shares:10.31M
Float Shares:10.02M
Volume Ratio:0.28
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2500
EPS(LYR):-5.5698
ROE:-11.20%
ROA:-0.60%
PB:1.81
PE(LYR):-1.22

Loading ...

ATIF Holdings Agrees to Acquire GoldCoin Labs in $20 Million Share Deal

Reuters
·
Jul 31

Atif Holdings Limited Enters into Definitive Agreement to Acquire Goldcoin Labs Limited

Reuters
·
Jul 31

ATIF Holdings Ltd: Agreed to Issue 2,815,005 Ordinary Shares, Par Value $0.001 Per Share, to Goldcoin's Sole Shareholder

THOMSON REUTERS
·
Jul 31

ATIF Holdings Ltd - upon Completion of Transaction, Goldcoin Will Become a Wholly Owned Subsidiary of ATIF

THOMSON REUTERS
·
Jul 31

ATIF Holdings Ltd - Transaction Consideration is Valued at $20 Mln

THOMSON REUTERS
·
Jul 31

NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am

Reuters
·
Jul 29

Press Release: Canadian Utilities Reports Second Quarter 2026 Earnings

Dow Jones
·
Jul 29

New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition

GlobeNewswire
·
Jul 22

ATIF Holdings Ltd - Appoints Kamran Khan as Interim CFO

THOMSON REUTERS
·
Jul 16

ATIF Holdings Ltd Announces Resignation of Shibin Yu as CFO and Director - SEC Filing

THOMSON REUTERS
·
Jul 16

ATIF Holdings Ltd - Co's Board Conducts a Search for a Permanent CFO

THOMSON REUTERS
·
Jul 16

ATIF Holdings Names CEO Kamran Khan Interim CFO After Shibin Yu Resigns

Reuters
·
Jul 16

NASDAQ Trade Halt Volatility Trading Pause at 09:30 Am

Reuters
·
Jun 29

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:38 PM

Reuters
·
Jun 24

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

GlobeNewswire
·
Jun 15

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:13 AM

Reuters
·
Jun 12

Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003)

GlobeNewswire
·
Jun 09

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:51 PM

Reuters
·
Jun 09

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

GlobeNewswire
·
Jun 06

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:00 PM

Reuters
·
Jun 05